3.81 USD
↗ 0.03 (0.66%)AT CLOSE (03:59 PM EDT)
SCYNEXIS, Inc.
SCYXNASDAQ • USD
3.79
↘ 0.02 (0.52%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
3.79
↘ 0.02 (0.52%)
Market: CLOSED
SCYX is currently priced at $3.76. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest SCYX is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Oct 26, 2026.
Open?$3.78
High?$3.90
Low?$3.78
Prev. Close?$3.79
Volume?64.0K
Avg. Volume?396.4K
VWAP?$3.86
Rel. Volume?0.16x
Bid / Ask
Bid?$3.80 × 100
Ask?$4.07 × 500
Spread?$0.27
Midpoint?$3.94
Valuation & Ratios
Market Cap?37.9M
Shares Out?9.9M
Float?9.0M
Float %?90.3%
P/E Ratio?N/A
P/B Ratio?0.57
EPS?-$1.03
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.
Employees
29
Market Cap
37.7M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2014-05-02
Address
1 EVERTRUST PLAZA
JERSEY CITY, NJ 07302-6548
Phone: 201-884-5485
JERSEY CITY, NJ 07302-6548
Phone: 201-884-5485
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?0
Momentum?50
Short Sent.?65
Piotroski F-Score?3/9Weak
Altman Z-Score?-4.55Distress
Confidence?52%Low
Short InterestLow
Short % of Float?4.68%Low
Short Interest?420.5K
Days to Cover?2.3
Free Float9.0M
Avg Daily Volume185.0K
Settlement Date2026-10-15
Financial Health
Current Ratio?9.65Strong
Quick Ratio?9.65Strong
Cash Ratio?1.80Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.57CHEAP▾
Peers100
S&P97
P/S?1.97CHEAP▾
Peers100
S&P67
P/FCF?N/A▾
EV/EBITDA?-1.2CHEAP▾
S&P97
EV/Sales?1.43CHEAP▾
Peers100
S&P85
Returns & Efficiency
ROE?-15.3%WEAK▾
S&P8
ROA?-13.7%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-13309000
Enterprise Value?$27.4M
Fundamentals ratios updated end of day